| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.052 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |